Trials / Unknown
UnknownNCT00591292
Phase I Study in Advanced Solid Tumors
IBL1002:Phase I Study of Indibulin in Advanced Solid Tumors
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 22 (actual)
- Sponsor
- Alaunos Therapeutics · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Dose escalating study of orally administered indibulin at twice daily schedule in subjects with solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | indibulin | Dose escalation of indibulin given twice daily for up to 6 months |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2013-06-01
- Completion
- 2013-06-01
- First posted
- 2008-01-11
- Last updated
- 2012-07-19
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00591292. Inclusion in this directory is not an endorsement.